SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is at the center of investor focus as its Worldwide Developers Conference triggers aggressive volatility and a classic 'sell the news' reaction, with the community intensely debating the impact of its new AI strategy and reliance on Google Cloud infrastructure. Traders are closely monitoring key support levels near $300 and discussing whether the stock's high valuation is justified following the mixed reception of its latest AI features.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending following reports of a major AI chip deal with ByteDance and an upbeat outlook on its data center and automotive segments, fueling investor excitement about the company's pivot beyond mobile handsets. Community members are actively debating the stock's valuation as it tests all-time highs, with many traders analyzing whether the company can successfully capture a larger share of the AI infrastructure market against competitors.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense downward pressure as investors rotate out of software and mega-cap tech amid concerns over heavy AI-related capital expenditures and broader market volatility. The community remains deeply divided, with bears pointing to the stocks recent decline as evidence of an overvaluation and a lost AI race, while bulls view the pullback as a long-term entry opportunity into a fundamentally strong, free-cash-flow-positive giant.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is seeing intense community scrutiny as investors express deep frustration over the company's communication, leadership, and management's requests for additional equity compensation despite a stagnant share price. Meanwhile, discussions have shifted toward Novavax's proprietary combination vaccine assets and potential involvement in emerging Ebola outbreak responses as critical catalysts that the community believes management must capitalize on to drive value.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is trending as community members rally behind the company's pivot toward becoming an AI infrastructure heavyweight, specifically highlighting the scale of its Helios data center project. Investors are actively debating the stock's decoupling from crypto volatility, with many pinning bullish sentiment on the anticipation of new tenant announcements and potential partnerships to fully leverage the site's massive power capacity.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis

Trulieve is trending as investors gear up for its historic NYSE uplisting, with the community closely tracking CEO Kim Rivers anticipated role in the opening bell ceremony. Speculation is high regarding institutional demand and the companys potential as a first-mover in a newly maturing U.S. cannabis market.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant investor attention as the community anticipates imminent 52-week clinical data, which is widely viewed as a pivotal catalyst for a potential M&A event. Traders are actively discussing the stock's positioning ahead of major industry conferences, with many speculating that strong data could trigger a bidding war among major pharmaceutical suitors.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending after securing a major 15-year lease for its fifth AI campus, driving a massive increase in total contracted revenue and fueling community excitement over the company's rapid expansion. Investors are actively discussing the firm's robust backlog, the role of investment-grade hyperscalers, and expectations for a significant stock re-rating as these projects shift from development to operational cash flow.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as investors monitor reports that U.S. antitrust regulators appear increasingly willing to approve the Warner Bros. Discovery acquisition following constructive meetings regarding theatrical release commitments. The community remains deeply divided, with some shareholders expressing frustration over prolonged price suppression and ongoing litigation hurdles while others maintain confidence that the strategic merger will ultimately unlock long-term value.

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in Brisbane, CA.

Nurix Therapeutics Inc

Nurix Therapeutics is currently in the spotlight following the announcement of a multibillion-dollar collaboration with Roche to develop a blood cancer drug, a move seen by the community as major validation for their targeted protein degradation platform. While some analysts have adjusted their price targets, investors are actively debating the long-term potential of this deal, with many focusing on the bolstered cash position and the reduction of future development risk.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Verano Advances U.S. Exchange Uplisting Plans: Time to Invest?

VRNO's reverse split and prior U.S. redomestication support potential exchange uplisting plans as the company expands stores and product offerings.

Curaleaf Prepares for US Exchange Uplisting: Time to Invest?

CURLF's reverse stock split and Delaware domestication plan signal preparation for a potential U.S. uplisting as revenue and international growth improve.

Schedule III for Some, Not All: Understanding the DOJ's Cannabis Shift

DOJ narrows cannabis reform, shifting select marijuana products to Schedule III while leaving broader federal restrictions intact.

Green Thumb Industries Inc. (GTBIF) Moves 10.0% Higher: Will This Strength Last?

Green Thumb Industries Inc. (GTBIF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Weedcoin Jumps In Minutes After Trump’s Marijuana Shake-Up Speculation Sparks Sector Frenzy

Cryptocurrency

Cannabis stocks and ETFs rallied sharply, with names like TLRY, GTBIF, TCNNF, and IIPR jumping 6% to over 20% in midday trade.

Curaleaf Launches Buyback Program: Time to Get Bullish on the Stock?

CURLF's $83M buyback lifts shares, but U.S. pricing pressure and rising losses cloud the outlook despite strong international growth momentum.

Boston Scientific (BSX) Q1 Earnings Match Estimates

Boston Scientific (BSX) delivered earnings and revenue surprises of +0.59% and +0.37%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Cannabis Operator GTBIF Stock Down 17% YTD: Should You Buy the Dip?

Green Thumb has lost 17% YTD as pricing pressure and competition weigh, but steady revenue growth and strong cash flow raise the question: Is the dip worth buying?

Cannabis Stock VRNO Rises 40% in a Year: Time to Buy, Sell or Hold?

Verano stock has surged more than 40% in a year amid U.S. marijuana rescheduling optimism, but revenue headwinds and rising competition may keep investors cautious.

Should You Buy GTBIF Stock After Marijuana Reclassification Order?

Shares of Green Thumb GTBIF jump nearly 35% on a marijuana rescheduling order, but pricing pressure and weak comps cloud the stock's near-term outlook.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Extremely Bullish Sentiment

Green Thumb Industries

Investors are eagerly anticipating a formal move to major exchanges, viewing it as the primary catalyst for significant long-term growth.

GTBIFGreen Thumb Industries

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GTBIF News